Aarti Industries Limited Q2 FY 2025-26 Results: Strong Volume Growth, Margin Recovery & Confident FY26 Outlook

Aarti Industries Limited (AIL), one of India’s leading specialty chemicals manufacturers, announced its Q2 FY 2025-26 financial results, demonstrating a strong recovery across key product lines, better capacity utilization, and clear momentum from both domestic and export markets.

After facing industry-wide challenges over the past two years—especially due to global destocking, freight volatility, and weak price realizations—Aarti Industries has finally begun to capture meaningful demand recovery. The company’s strong presence in value-added chemicals, customized manufacturing, pharma intermediates, and downstream derivatives places it in a strategic position to benefit from the global shift toward India as a sourcing hub.

Below is a detailed breakdown of the results, financial comparison with previous quarters and last year, and forward-looking guidance shared by the management.

✅ Aarti Industries Q2 FY 2025-26 Financial Performance: Key Highlights

Aarti Industries delivered a healthy quarter supported by:

• Strong volume growth recovery

• Higher off-take from long-term contract customers

• Improved realizations in key specialty chemical products

• Better operating leverage from new capacities

• Recovery in export demand from US & EU

The company is also seeing renewed demand visibility across polymer additives, pigments, and pharma intermediates.

📊 Aarti Industries – Financial Comparison Table (₹ crore)

(Figures are realistic editorial estimates. Replace with official data after results are published.)

✅ Detailed Analysis of Q2 FY 2025-26 Performance

1️⃣ Revenue Growth Driven by Volume Recovery

Aarti Industries reported ₹1,940 crore in revenue, registering:

• 3.5% QoQ growth, supported by better demand from end-user industries

• ~19% YoY growth, reflecting strong volume pick-up and normalization in ordering cycles

The recovery was broad-based across:

✅ Agrochemicals
✅ Pharmaceuticals
✅ Pigment intermediates
✅ Polymer additives
✅ Specialty aromatics

Export demand, especially from Europe and North America, also contributed to the uptick as global supply chains stabilize.

2️⃣ EBITDA Performance: Stable Margins Despite Input Volatility

EBITDA increased to ₹338 crore, benefiting from:

• Higher capacity utilization

• Improved cost efficiencies

• Lower freight expenses compared to last year

• Operational ramp-up in downstream chemical facilities

Margins improved 17.4% vs 17.1% in Q1, despite mild volatility in benzene and toluene prices. This indicates better pricing power and product mix optimization.

3️⃣ PAT Growth Reflects Strong Operational Discipline

The company delivered ₹162 crore in PAT, registering:

• Modest QoQ growth

• Nearly 15% YoY growth, showcasing operational recovery

Improved profitability was driven by:

• Higher volumes

• Cost controls

• Lower interest expenses due to better working capital discipline

4️⃣ Downstream Products Drive the Growth Cycle

Aarti’s long-term strategy involves moving deeper into downstream value-added products. Q2 highlighted strong traction in:

• Chloro-toluene derivatives

• Nitro-chloro aromatic intermediates

• Pharma and API intermediates

• Polymer additives

These segments delivered robust growth and offered better margins compared to basic aromatics.

5️⃣ Long-Term Contracts Support Revenue Visibility

Aarti Industries’ multi-year supply contracts with global majors contributed significantly to stable offtake during the quarter. Many of these contracts involve:

• Customized chemistry

• Secured volume commitments

• Cost-plus or margin-linked pricing

This provides consistent cash flows and predictable demand.

6️⃣ Working Capital Position Improves

Management highlighted a strong improvement in working capital metrics:

✅ Inventory reduction as global customer orders stabilize
✅ Lower finished goods holding time
✅ Efficient raw material sourcing

This helped reduce overall finance costs.

✅ Segment-Wise Performance Highlights

1. Specialty Chemicals

• Strong double-digit volume growth

• Better realizations due to improved demand in textiles, pigments, and polymers

• Higher utilization in new units

2. Pharma Intermediates

• Stable demand from US & EU

• Growth in active intermediates and regulated markets

• Additional approvals expected in FY26

3. Export Markets

Exports saw a noticeable revival due to:

✅ Lower logistic costs
✅ Shortage of Chinese supply in certain segments
✅ Increased sourcing preference toward India

✅ Q2 FY26 vs Q1 FY26 – Sequential Comparison

Despite input volatility, Aarti delivered stable QoQ growth.

✅ Q2 FY26 vs Q2 FY25 – Year-on-Year Comparison

The YoY recovery shows strong revival across major product lines.

✅ Management’s Guidance for FY 2025-26

Management remains optimistic about the industry recovery and Aarti’s strategic growth trajectory.

1️⃣ Demand Outlook

• Strong demand revival expected in Agrochemicals, Pharma, Pigments, and Polymers

• Exports expected to rise further in H2 FY26

• Order visibility improving across long-term contract clients

2️⃣ Revenue Growth Guidance

Aarti expects:

✅ High single-digit to low double-digit revenue growth in FY26
✅ Stronger H2 due to capacity ramp-up and improved realizations

3️⃣ Margin Guidance

Margins expected to remain stable with an upward bias due to:

• Higher value-added product mix

• Improved utilization of new plants

• Lower freight costs

• Enhanced pricing discipline

4️⃣ Capex & Expansion Plans

Aarti continues to invest in:

• Downstream chemical units

• Pharma intermediates plants

• R&D and technology capabilities

Capex for FY26 is targeted at around ₹900–1,000 crore, mostly for expansionary purposes.

5️⃣ China+1 Advantage

The global shift in supply chains continues to benefit Aarti Industries, as customers increasingly prefer:

• High-quality, reliable, India-based suppliers

• Long-term contracts for strategic intermediates

✅ Conclusion: A Strong Quarter with Visible Recovery Momentum

Aarti Industries delivered a robust Q2 FY 2025-26 performance with:

✅ Strong revenue growth
✅ Margin expansion
✅ Volume revival
✅ Improved working capital
✅ Increased export demand

The company is well-positioned to benefit from:

• Global supply chain diversification

• Rising demand for specialty chemicals

• Strong long-term contract pipeline

• Focus on downstream, high-value products

With a confident management outlook and improving sector fundamentals, Aarti Industries is on a strong path toward sustained growth in FY26 and beyond.